La Jolla Pharmaceutical Co. (LJPC) shares are surging above 30% in pre-market today, after the company announced that it is providing GIAPREZA (angiotensin II) in Italy for compassionate use in patients with septic shock associated with COVID-19.
from RTT - Before the Bell https://ift.tt/2Wa9JZb
via IFTTT
No comments:
Post a Comment